ESTRO 35 2016 S929 ________________________________________________________________________________ and using the same patient anatomy and fractionation schedule virtual plans for intensity modulated radiotherapy (IMRT) were made. The PTV in IMRT plans was created by 5 mm volumetric extension around the PTV used in BT plans. PTVeval was formed from PTV with geometrical limitation to the skin. Detailed dose-volume histogram analysis was carried out for the PTVs, breasts, lungs, skin, ribs and heart. Means, standard deviations were calculated and the corresponding parameters were statistically compared. Wilcoxon matched pairs analysis was performed for test of significance.
EP-1958
Purpose or Objective: To report the initial outcomes of patients treated with the MammoSite brachytherapy device (MSBT) as a boost followed by external whole breast irradiation (WBI).
Material and Methods:
From June 2011 to March 2014, 107 patients (typically pT1-2, pN0-1, M0) were treated with breast-conserving therapy (BCT) and adjuvant radiotherapy with MSBT (15 Gy in 2.5 Gy fractions) followed by WBI (median 50.4 Gy). Toxicity was classified according to the Common Terminology Criteria for Adverse Events v3.0. The median follow-up was 21 months.
Results: So far no ipsilateral breast-tumor recurrences were observed, 102 patients (95%) were alive at last follow-up. Two patients (2%) developed distant metastasis. Five patients (5%) died during follow-up, only one as a result of breast cancer. The 2-year disease-free survival was 95 ± 3%. The incidence of asymptomatic and symptomatic seroma in 90 days after MSBT was 28% and 10%, respectively. Infectious mastitis was observed in 3 patients (3%), who were treated successfully with antibiotics. Only 3 patients (3%) developed a radiodermatitis > grade 2 after WBI.
Conclusion:
The boost technique used in this study seems to provide excellent local control with acceptable toxicity, similar to the results observed with other forms of interstitial accelerated partial-breast irradiation as a boost. Long-term follow-up is necessary to refine the patient selection criteria and to assess efficacy and late toxicities. Material and Methods: A retrospective study was performed on 25 patients treated in the 2013-2015 period with APBI brachytherapy. The CT scans of each patient taken before each treatment were imported in to the planning system. Each CT scan was registered with the initial one. Dosimetric evaluations respective to the initial CT scan image series were performed. The deviation of dose received by the skin and ribs in each treatment were calculated and minimum, maximum and average dose received by skin and ribs were recorded and compared to the initial plan's results.
EP-1959
Results: Small deviations in displacements were observed from the SAVI applicator to the ribs and the skin surface. Dosimetric evaluations revealed, very small changes in the inter-fractionation position make significant differences in the maximum dose to these critical organs. As a result, the maximum dose varied between 10% and 32% in ribs and skin surface.
Conclusion:
The CT scan before each treatment is necessary to minimize the uncertainty in setup and any intervention if deemed necessary. This study indicates, in 30% of the cases needed re-planning between treatments to minimize the risk of critical organs to be overdosed. We conclude that the physicist should evaluate the position of the device by analyzing the CT images before each treatment and consider re-planning is the deviations are high. Also this study reveals the urgent need of improving the immobilization methods when treating APBI with SAVI applicator. This type of treatment will benefit of deformable registration at each treatment and adaptive planning Material and Methods: From January 2010 to December 2014 we studied 108 pts with EC treated with exclusive BRT. Treatment was performed with cylinder in vagina to sterilize vaginal cuff, fractionation 6 -30 Gy, prescription to 0.5 cm from surface of cylinder, active length almost 3 cm. We evaluated efficacy, quality of life and impact on sexual activity after BRT filling out a test designed to investigate following areas: 1) social relations and personal emotions, 2) couple intimacy and sexuality , 3) impact of treatment on sexuality and doctor-patient relationship before BRT Results: 96 evaluable pts median follow-up 24 months (range 9-60); median age 62 years (40-88); histology revealed 2 cr. squamous and 94 adenocarcinoma; grading G1 for 15% , G2 for 65% and G3 for 20% of cases; all pT1b stage; lymph node status performed in 72 (75%) pts. median 4 (0-40) in other 24 (25%) NX; diameter of the cylinder used in 76 (84%) pts. was 3-4 cm remaining 20 (26%) diameter 1-2. Only 3 (3%) pts resulted disease progression. Psychological evaluation was performed on 69 pts (Median age 61; 44 -71), the other 27 cannot be estimated because not interested. In the first area test showed for a third of pts a change of social relations judged value "from much up to very much", while in half of respondents, there was same value in personal sphere. Considering couple intimacy the 71% of women had undergone a change, and 81% reported decrease of sexual desire. In third area half of pts said they were informed about impact of BRT on sexual life evaluating changes induced by it " from much up to very much"; 71% of women surveyed have been recommended to have therapeutic relationships, 73% of respondents reported painful intercourse and 91% of pts found it unsatisfactory. 13% of pts has explicitly requested psychological support Conclusion: Apart from grading and lymph node status, BRT of vaginal cuff is effective in preventing local recurrence. Despite of use of larger diameter cylinders, remains problem of toxicity management post BRT. Analysis of impact on quality of life of these pts causes several issues: whether treatment should always be recommended, if we have to review informed consent and if a psychological support pretreatment is necessary. An appropriate supportive therapy during and after BRT is always necessary 
